_id

690da856ccc777a4e85d07d5

Ticker

ABOS

Name

Acumen Pharmaceuticals Inc

Exchange

NASDAQ

Address

1210-1220 Washington St., Newton, MA, United States, 02465

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://acumenpharm.com

Description

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Last Close

1.96

Volume

158071

Current Price

2.14

Change

9.183673469387763

Last Updated

2025-11-28T11:45:19.145Z

Image

data:image/webp;base64,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

Ipo Date

2021-07-01T00:00:00.000Z

Market Cap

118118176

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

5

Target Price

6.5

Strong Buy

5

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

26513000

Operating Income

-26513000

Interest Expense

1068000

Pretax Income

-26451000

Net Income

-26451000

Eps

-0.43667664491482855

Dividends Per Share

-

Shares Outstanding

60573425

Income Tax Expense

-

EBITDA

-25383000

Operating Margin

-

Total Other Income Expense Net

62000

Cash

46832000

Short Term Investments

79777000

Receivables

379000

Inventories

-

Total Current Assets

132153000

Property Plant Equipment

288000

Total Assets

142221000

Payables

682000

Short Term Debt

3744000

Long Term Debt

27053000

Total Liabilities

49048000

Equity

93173000

Depreciation

-260000

Change In Working Capital

-7026000

Cash From Operations

-30489000

Capital Expenditures

0

Cash From Investing

40511000

Cash From Financing

0

Net Change In Cash

10022000

PE

-

PB

1.3912520740987195

ROE

-28.38912560505726

ROA

-18.598519206024427

FCF

-30489000

Fcf Percent

-

Piotroski FScore

0

Health Score

38

Deep Value Investing Score

5

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

1.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

26513000

Quarters > 0 > income Statement > operating Income

-26513000

Quarters > 0 > income Statement > interest Expense

1068000

Quarters > 0 > income Statement > pretax Income

-26451000

Quarters > 0 > income Statement > net Income

-26451000

Quarters > 0 > income Statement > eps

-0.43667664491482855

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

60573425

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-25383000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

62000

Quarters > 0 > balance Sheet > cash

46832000

Quarters > 0 > balance Sheet > short Term Investments

79777000

Quarters > 0 > balance Sheet > receivables

379000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

132153000

Quarters > 0 > balance Sheet > property Plant Equipment

288000

Quarters > 0 > balance Sheet > total Assets

142221000

Quarters > 0 > balance Sheet > payables

682000

Quarters > 0 > balance Sheet > short Term Debt

3744000

Quarters > 0 > balance Sheet > long Term Debt

27053000

Quarters > 0 > balance Sheet > total Liabilities

49048000

Quarters > 0 > balance Sheet > equity

93173000

Quarters > 0 > cash Flow > net Income

-26451000

Quarters > 0 > cash Flow > depreciation

-260000

Quarters > 0 > cash Flow > change In Working Capital

-7026000

Quarters > 0 > cash Flow > cash From Operations

-30489000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

40511000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

10022000

Quarters > 0 > ratios > PE

-0.43667664491482855

Quarters > 0 > ratios > PB

1.3912520740987195

Quarters > 0 > ratios > ROE

-28.38912560505726

Quarters > 0 > ratios > ROA

-18.598519206024427

Quarters > 0 > ratios > FCF

-30489000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

41750000

Quarters > 1 > income Statement > operating Income

-41750000

Quarters > 1 > income Statement > interest Expense

1046000

Quarters > 1 > income Statement > pretax Income

-40950000

Quarters > 1 > income Statement > net Income

-40950000

Quarters > 1 > income Statement > eps

-0.6760390385717829

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

60573425

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-39857000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

800000

Quarters > 1 > balance Sheet > cash

36810000

Quarters > 1 > balance Sheet > short Term Investments

106559000

Quarters > 1 > balance Sheet > receivables

315000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

148404000

Quarters > 1 > balance Sheet > property Plant Equipment

335000

Quarters > 1 > balance Sheet > total Assets

171897000

Quarters > 1 > balance Sheet > payables

2103000

Quarters > 1 > balance Sheet > short Term Debt

142000

Quarters > 1 > balance Sheet > long Term Debt

29882000

Quarters > 1 > balance Sheet > total Liabilities

54820000

Quarters > 1 > balance Sheet > equity

117077000

Quarters > 1 > cash Flow > net Income

-40950000

Quarters > 1 > cash Flow > depreciation

47000

Quarters > 1 > cash Flow > change In Working Capital

6275000

Quarters > 1 > cash Flow > cash From Operations

-31832000

Quarters > 1 > cash Flow > capital Expenditures

9000

Quarters > 1 > cash Flow > cash From Investing

38483000

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

6651000

Quarters > 1 > ratios > PE

-0.6760390385717829

Quarters > 1 > ratios > PB

1.1071955166258105

Quarters > 1 > ratios > ROE

-34.976980961247726

Quarters > 1 > ratios > ROA

-23.822405277579016

Quarters > 1 > ratios > FCF

-31841000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

45000

Quarters > 2 > income Statement > gross Profit

-45000

Quarters > 2 > income Statement > operating Expenses

30370000

Quarters > 2 > income Statement > operating Income

-30370000

Quarters > 2 > income Statement > interest Expense

1023000

Quarters > 2 > income Statement > pretax Income

-28796000

Quarters > 2 > income Statement > net Income

-28796000

Quarters > 2 > income Statement > eps

-0.4757654063498523

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

60525628

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-27728000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1574000

Quarters > 2 > balance Sheet > cash

30159000

Quarters > 2 > balance Sheet > short Term Investments

118989000

Quarters > 2 > balance Sheet > receivables

376000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

154947000

Quarters > 2 > balance Sheet > property Plant Equipment

373000

Quarters > 2 > balance Sheet > total Assets

204478000

Quarters > 2 > balance Sheet > payables

1056000

Quarters > 2 > balance Sheet > short Term Debt

138000

Quarters > 2 > balance Sheet > long Term Debt

28748000

Quarters > 2 > balance Sheet > total Liabilities

48957000

Quarters > 2 > balance Sheet > equity

155521000

Quarters > 2 > cash Flow > net Income

-28796000

Quarters > 2 > cash Flow > depreciation

45000

Quarters > 2 > cash Flow > change In Working Capital

-7362000

Quarters > 2 > cash Flow > cash From Operations

-34121000

Quarters > 2 > cash Flow > capital Expenditures

79000

Quarters > 2 > cash Flow > cash From Investing

28689000

Quarters > 2 > cash Flow > cash From Financing

-36000

Quarters > 2 > cash Flow > net Change In Cash

-5468000

Quarters > 2 > ratios > PE

-0.4757654063498523

Quarters > 2 > ratios > PB

0.8328447214202583

Quarters > 2 > ratios > ROE

-18.515827444525176

Quarters > 2 > ratios > ROA

-14.082688602196814

Quarters > 2 > ratios > FCF

-34200000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

41

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

178000

Quarters > 3 > income Statement > cost Of Revenue

44000

Quarters > 3 > income Statement > gross Profit

-44000

Quarters > 3 > income Statement > operating Expenses

39553000

Quarters > 3 > income Statement > operating Income

-39597000

Quarters > 3 > income Statement > interest Expense

1037000

Quarters > 3 > income Statement > pretax Income

-37154000

Quarters > 3 > income Statement > net Income

-37154000

Quarters > 3 > income Statement > eps

-0.6190963376320876

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

60013277

Quarters > 3 > income Statement > income Tax Expense

44000

Quarters > 3 > income Statement > EBITDA

-36073000

Quarters > 3 > income Statement > operating Margin

-22245.505617977527

Quarters > 3 > income Statement > total Other Income Expense Net

2443000

Quarters > 3 > balance Sheet > cash

35627000

Quarters > 3 > balance Sheet > short Term Investments

135930000

Quarters > 3 > balance Sheet > receivables

398000

Quarters > 3 > balance Sheet > inventories

159000

Quarters > 3 > balance Sheet > total Current Assets

178306000

Quarters > 3 > balance Sheet > property Plant Equipment

339000

Quarters > 3 > balance Sheet > total Assets

238992000

Quarters > 3 > balance Sheet > payables

5648000

Quarters > 3 > balance Sheet > short Term Debt

133000

Quarters > 3 > balance Sheet > long Term Debt

28449000

Quarters > 3 > balance Sheet > total Liabilities

57176000

Quarters > 3 > balance Sheet > equity

181816000

Quarters > 3 > cash Flow > net Income

-37154000

Quarters > 3 > cash Flow > depreciation

44000

Quarters > 3 > cash Flow > change In Working Capital

8221000

Quarters > 3 > cash Flow > cash From Operations

-27215000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

29663000

Quarters > 3 > cash Flow > cash From Financing

-9000

Quarters > 3 > cash Flow > net Change In Cash

2443001

Quarters > 3 > ratios > PE

-0.6190963376320876

Quarters > 3 > ratios > PB

0.70636474666696

Quarters > 3 > ratios > ROE

-20.43494521934263

Quarters > 3 > ratios > ROA

-15.546127067014796

Quarters > 3 > ratios > FCF

-27215000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-152.8932584269663

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.43667664491482855

Valuation > metrics > PB

1.3912520740987195

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-28.38912560505726

Profitability > metrics > ROA

-20.01543665297042

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.526418597662413

Risk > metrics > Interest Coverage

-24.824906367041198

Risk > final Score

-51

Risk > verdict

High

Liquidity > metrics > Current Ratio

29.858337098960686

Liquidity > metrics > Quick Ratio

29.858337098960686

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-100

Prev Risks > 1

-59

Prev Risks > 2

-93

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:11:27.020Z